Inferring the Serotype Associated with Dengue Virus Infections on the Basis of Pre‐ and Postinfection Neutralizing Antibody Titers
Author(s) -
Willem G. van Panhuis,
Robert V. Gibbons,
Timothy P. Endy,
Alan L. Rothman,
A Srikiatkhachorn,
Ananda Nisalak,
Donald S. Burke,
Derek A. T. Cummings
Publication year - 2010
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/656141
Subject(s) - serotype , plaque reduction neutralization test , dengue virus , virology , seroconversion , dengue fever , viremia , medicine , dengue vaccine , biology , titer , immunology , virus
Currently, the only tests capable of determining the serotype associated with dengue virus (DENV) infection require sampling during the period of acute viremia. No test can accurately detect the serotype associated with past DENV infections. The standard assay for determination of serotype-specific antibody against DENV is the plaque reduction neutralization test (PRNT), although performance of this test continues to be evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom